One in ten clinics in South Africa across 22 health districts in six provinces could start to hand out a twice-a-year anti-HIV jab as early as February.
The countrys medicines regulator, Sahpra, says its on track to announce its registration decision within the next 12 days, by the end of October.
If between one and two million HIV-negative people in the country take LEN each year, the shot could stop enough new infections to end Aids in the country within 1418 years, a modelling study shows.
But for the first phase of its roll-out, the country will only have enough doses to phase in 456 360 people on lenacapavir over two years.
So who should get LEN first for the highest impact? We break it down.
Intodays newsletter, Mia Malan asks who in SA should get LEN first.Sign up for our newsletter today.
One in ten clinics in South Africa across 22 health districts in six provinces could start to hand out a twice-a-year anti-HIV jab as early as February if the countrys medicines regulator approves the shot, called lenacapavir LEN, soon enough, says the health department.
Boitumelo Semete-Makokotlela, the head of the South African Health Products Regulatory Authority, Sahpra, says the body is on track to announce its registration decision within the next 12 days, by the end of October.